References
- Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, Salek MS, Graham-Brown RA, Double-bind, controlled, crossover study of ciclosporin n adults with severe refractory atopic dermatitis. Lancet. 1991;338:137–140.
- Salek MS, Finlay AY, Luscombe DK, Allen BR, Berth-Jones J, Camp RD, Graham-Brown RA, Khan GK, Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. a randomized, double-blind, placebo-controlled trial. Br J Dermatol. 1993;129:422–430.
- van Joost T, Heule F, Korstanje M, van den Broek MJ, Stenveld HJ, van Vloten WA. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol. 1994;130:634–640.
- Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, Cork MJ, Bleehen SS, Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol. 1996;34:1016–1021.
- Berth-Jones J, Graham-Brown RA, Marks R, Camp RD, English JS, Freeman K, Holden CA, Rogers SC, Long-term efficacy and safety of ciclosporin in severe adult atopic dermatitis. Br J Dermatol. 1997;136:76–81.
- Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ, Finlay AY, Wilson NJ, Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol. 2000;142:52–58.
- Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic dermatitis–a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007;21:606–619.
- Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European task force on atopic dermatitis. Dermatology. 1997;195:10–19.
- Bunikowski R, Mielke M, Bräutigam M, Renz H, Wahn U. Effect of oral ciclosporin A in children with Staphylococcus aureus-colonized vs S. aureus-infected severe atopic dermatitis. Pediatr Allergy Immunol. 2003;14:55–59.
- Campbell DE, Kemp AS. Cyclosporine restores cytokine imbalance in childhood atopic dermatitis. J Allergy Clin Immunol. 1997;99:857–859.
- Bunikowski R, Staab D, Kussebi F, Bräutigam M, Weidinger G, Renz H, Wahn U. Low-dose ciclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol. 2001;12:216–223.
- Schlievert PM, Case LC, Strandberg KL, Abrams BB, Leung DY. Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin Infect Dis. 2008;46:1562–1567.
- Suzuki H, Terai M, Hamada H, Honda T, Suenaga T, Takeuchi T, Yoshikawa N, Shibuta S, Cyclosporin A Treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Pediatr Infect Dis J. 2011;30:871–876.